At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our 39,000 employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world
Do you have expertise in metabolic physiology and insulin signaling? Are you a dedicated scientist with a passion to make life better for those living with type 1 and type 2 diabetes? The Diabetes and Complications Therapeutic Area (DCTA) at Lilly is looking for an In Vivo Pharmacologist – Insulin Biology, who can play a key role in developing the next wave of innovation in insulin therapeutics. You will establish a state-of-the-art research laboratory focused on developing in vivo models to study traditional and non-traditional insulin and glucagon receptor agonists. You should have strong knowledge and technical skills in the field of diabetes, metabolism, and body weight regulation with particular focus on the molecular mechanisms of insulin action. You will have the chance to define and progress your ideas from target identification to proof-of-concept testing in humans, working collaboratively with scientists in the DCTA and with internal and external partners. Are you inspired by the science and the desire to make a difference? Consider joining Lilly to make a positive impact on the lives of our patients.
Potential opportunities in this role include:
Discover and advance novel approaches to deliver insulin and glucagon therapy so that it is more efficacious, safer, and less cumbersome for the patient.
Design, conduct and supervise studies in preclinical in vivo models, aligning resources to meet short- and long-term goals.
Provide preclinical biology leadership on cross-functional project teams by partnering in a team-driven approach to expeditiously tackle challenges and advance projects.
Collaborate with colleagues working to enable next-generation insulin delivery devices including closed-loop artificial pancreas systems.
Maintain scientific expertise and presence in the external scientific community through publication, collaborations, and presentations in the areas of diabetes and metabolic disease.
Ph.D. with at least 1 year of relevant post-doc or work experience
In-depth expertise/experience in diabetes pathophysiology and in vivo pharmacology is required
Expertise in subcutaneous biology and absorption of therapeutic compounds from subcutaneous tissues is desired but not required.
Knowledge of glucagon biology/pharmacology is a plus.
Proven track record of scientific accomplishments as evidenced by high impact publications.
Ability to work collaboratively with diverse groups while advancing project and strategic goals.
Excellent oral and written communication skills.
Previous supervisory experience and expertise in drug discovery a plus.
Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status